In an analysis of lymphocyte functions of systemic lupus erythematosus (SLE) patients, B 
Introduction
In vitro assessment of lymphocyte function is of crucial importance in the analysis of the pathogenesis of disease with immunologic dysfunctions, such as immunodeficiency, autoimmune, and lymphoproliferative diseases.
Systemic lupus erythematosus (SLE)1 is a disease characterized by disordered immune regulation. Hyperactive B cells are known to synthesize excessive amount of autoantibodies (1, 2) 1. Abbreviations used in this paper: BCDF, B cell differentiation factor; Cowan I, Staphylococcus aureus strain Cowan I; FCS, fetal calf serum; ISC, immunoglobulin-secreting cell(s); PBMC, peripheral blood mononuclear cell(s); PFC, plaque-forming cell(s); PHA, phytohemagglutinin; PWM, pokeweed mitogen; SLE, systemic lupus erythematosus; TdR; thymidine. and other immunoglobulins (3, 4, 5, 6) . In addition, abnormalities of T cell subsets, particularly a deficiency of suppressor T cells (7, 8, 9, 10) , or abnormalities of macrophages (1 1, 12) were reported to have association with this B cell hyperactivity. However, it has been unclear whether the B cell hyperactivity in SLE is independent of the abnormalities in T cells or macrophages and whether the B cell hyperactivity may preceed or result from the other cell abnormalities.
In recent years, advances in the therapy for SLE made it possible to decrease death from the renal failure. Consequently the survival time of the SLE patients has increased (13, 14) . However, infection has always been acknowledged as a major factor in morbidity and mortality suggesting the presence of an immunodeficient state in this disease (15) .
Previously, we described methods to detect B cell functions of proliferation and differentiation to immunoglobulin-secreting cells (ISC) separately with either Staphylococcus aureus strain Cowan I (Cowan I) or B cell differentiation factor (BCDF) (16) , and also showed three distinct stages of B cell defects in common variable immunodeficiency (17) .
In the present study, we have investigated the B cell functions of proliferation and differentiation to ISC in SLE patients and found such B cell abnormalities as a lack of mitogen-responsive B cells and a predominance of spontaneous IgA-SC.
Methods
Cellpreparations. Peripheral blood mononuclear cells (PBMC) ofpatients with SLE and normal adult volunteers were obtained by centrifuging heparinized venous blood on Ficoll-Hypaque and three washes in Hanks' balanced salt solution (HBSS). B and T cells were separated by one or two cycles of rosetting with neuraminidase-treated sheep erythrocytes, followed by Ficoll-Hypaque centrifugations (16) . Adherent cells were partially depleted by incubation for 4 h on petri dishes in culture medium (RPMI-1640) containing penicillin, streptomycin, 0.2 mM glutamine, and 10% fetal calf serum (FCS). Contamination of monocytes or T cells in the B cell fractions was <1% by esterase staining and <0.5% by OKT 3 monoclonal antibody, respectively.
Cell culture. All cultures were carried out in RPMI-1640 medium supplemented with 100 U of penicillin/ml, 100 ,g of streptomycin/ml, 0.2 mM glutamine, and 10% FCS (Sterile Systems, Logan, UT).
Cells were cultured in flat-bottomed microtiter plates (3040, Falcon Plastics Co., Oxnard, CA) in triplicate with each microwell containing 2 X 105 cells in 0.2 ml of culture medium. Mitogen dissolved in HBSS or an equivalent volume of HBSS as control was added to the wells, and they were incubated for (a given number of days) or Table I . Preparations of class-specific antibodies were chosen to give maximum plaques with the homologous cell line and no plaque with the other lines. Anti-IgE antibody was prepared by the immunization of rabbits with purified IgE and the antiserum was made monospecific by extensive adsorption on a normal IgG-conjugated Sepharose column, and the anti-IgE antibody was specifically purified by affinity chromatography through an IgE Sepharose column (22 BCDF. Mononuclear cells were isolated from a patient's spleen which was pathologically not involved. The cells were irradiated with 1,000 rads (1 rad = 2.58 X 104 Ci/kg) to enhance the factor production (23) and cultured at 2 X 105 cells per ml in 1% FCS with 0.25% PWM for 2 d. The supernatant was concentrated 20-fold by Amicon pressure filtration (Amicon Corp., Danvers, MA) and the material precipitating between 33 and 88% (vol/vol) ammonium sulfate was applied for fractionation on a Sephadex G-100 column as described previously (23) . The 15,000-20,000 mol wt material is designated BCDF.
Patients. 20 SLE patients were studied who all fulfilled the American Rheumatism Association criteria for SLE (24) . There were 3 men and 17 women ranging in age from 20 to 45 yr. Most of the patients were in an inactive state of the disease, but four patients were in the active state. All patients were receiving corticosteroids ranging in dose from 2.5 to 20 mg of prednisolone per day. In addition, two patients had received cyclophosphamide or azathiopurine previously, but not at the time of this study.
Results
Lack of mitogenic response to B cell mitogens in SLE. PBMC of healthy volunteers and SLE patients were obtained by FicollHypaque centrifugation. PBMC were stimulated for 72 h in the The response of SLE cells to Cowan I was significantly depressed compared to normals (P < 0.005). SI, stimulation index.
presence ofeither T cell mitogen (PHA) or B cell mitogen (Cowan I). Lymphocytes of healthy volunteers showed strong mitogenic responses to both PHA and Cowan I. Similarly, strong mitogenic responses to PHA were also observed in PBL ofthe SLE patients, whereas mitogenic responses to Cowan I were absent or extremely weak in most patients as shown in Fig. 1 (P < 0.005). Additional experiments were undertaken to determine whether the impaired response to Cowan I was due to the effects of T cells or macrophages. Partially purified B cells, depleted of T cells and macrophages, were cultured either with Cowan I or PHA to determine DNA synthesis on day 3 of culture. No mitogenic response to Cowan I was observed in SLE B cells, whereas a striking mitogenic response to Cowan I was obtained in healthy controls (Table II) . As a control for the effects of prednisolone therapy, the responses of rheumatoid arthritis and asthma patients treated with the corticosteroid were normal (Table II) . These results suggest that weak or no mitogenic responses to B cell mitogen observed in SLE patients are due to neither the direct effects of suppressor T cells nor suppressor macrophages.
Predominance ofspontaneous IgA-SC in SLE. ISC were examined at days 0-6 after culture of PBMC in the absence of Cowan I or PWM by reverse plaque assay (Fig. 2) Further experimentation to examine many other SLE patients was carried out in order to confirm these observations. In most SLE patients, high numbers of spontaneous IgA-SC were observed, and IgM-and IgG-SC were low or undetectable (Fig.  3) . In healthy controls, low numbers of spontaneous ISC were 1)000- (16) , and ISC were determined on day 6 of culture by reverse plaque assay. Many ISC were detected in healthy volunteers (Fig. 4) . In contrast, very low numbers of ISC were observed in the patients. The time course of the induction of ISC was investigated to determine whether different kinetics would account for the failure of induction of ISC in SLE. IgM-, IgG-, and IgA-SC were examined at days 0-8. The greatest number of ISC was observed in healthy controls on day 6 IgA-SC as shown in Fig. 2 . These results eliminate the possibility that the failure to induce ISC in SLE patients by mitogens was due to a shift of the kinetics of Ig secretion. Additional experiments were performed to determine whether the failure ofdifferentiation to ISC was due to the effects of T cells or macrophages. Partially purified B cells, depleted of T cells and macrophages, were cultured with Cowan I and partially purified BCDF (Table IV) . ISC were assayed on day 6 of culture. Neither Cowan I nor BCDF alone succeeded in induction of ISC from both healthy and SLE B cells. A significant number of IgM-, IgG-, and IgA-SC were detected in healthy controls when stimulated with Cowan I and BCDF, whereas only few ISC were observed in SLE patients. Arthritis and asthma patients treated with prednisolone similarly to SLE patients showed normal ISC inductions (Table IV) . These results suggest that the failure to induce ISC in SLE is not due to the in vitro direct effects of T cells or macrophages.
Discussion
The studies presented here were undertaken to examine the immunologic function of B cells obtained from patients with SLE. They were found to have such B cell abnormalities as impaired proliferative response to B cell mitogens, predominance of spontaneous IgA-SC, and failure to differentiate to ISC when stimulated by Cowan I and BCDF.
Most spontaneous ISC in SLE patients were of the IgA isotype. To our knowledge, this has never been described in previous reports. Employing either the reverse plaque assay (5, 6, 11, 12, 25, 26) or radioimmunoassay (27) , antigen-specific or antigennonspecific spontaneous Ig secretion was reported in SLE. In previous experiments by other investigators, IgG was documented to be the major isotype ofIgs secreted. Using an antigennonspecific reverse plaque assay similar to ours, Ginsberg et al. (25) (29) . (2, 5) . The reason why these hyperactive B cells are generated is not yet clear, but several possibilities could be considered. It is probable that loss of suppressor T cell subset (7-9), or several autoantibodies (1, 2) may cause the generation of these state. In this study a decrease of Ts subsets, Leu 2a, was also observed in most of the patients (data not shown) as was reported by others (7) (8) (9) . It is also conceivable that unknown serum factor(s) at the onset of illness may trigger B cell activation and then hyperactive B cell may not respond to further stimulation in vivo or in vitro (2, 5, 32) .
It is unlikely that the abnormalities observed in the present studies were due to the effects of corticosteroid therapy which most of the patients were receiving, because the patients with rheumatoid arthritis and bronchial asthma who had received similar corticosteroid therapy had normal responsiveness to in vitro stimulation with Cowan I and BCDF (Tables II and IV) . It is still unclear why many spontaneous IgA-SC appear in the peripheral blood of SLE patients in whom this phenomenon may have been as yet unappreciated. We hope that these observations will provide the basis for further and more sophisticated delination of immunoregulatory abnormalities in this disease.
